Treating Alcohol Use In Older Adults With Depression
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00018824 |
Recruitment Status :
Completed
First Posted : July 5, 2001
Last Update Posted : September 23, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Alcoholism Depression | Drug: NALTREXONE Drug: Placebo | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 74 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | The Treatment of Late Life Major Depression Complication by Alcohol |
Study Start Date : | October 1999 |
Actual Primary Completion Date : | January 2005 |
Actual Study Completion Date : | January 2005 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
Naltrexone
|
Drug: NALTREXONE |
Placebo Comparator: 2
Placebo
|
Drug: Placebo |
- Alcohol use' [ Time Frame: 12 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age > 55
- Current depressive syndrome
- Current alcohol dependence
- No psychosis
- No opioid or cocaine abuse or dependence
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018824
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 |
Principal Investigator: | David W. Oslin, MD | University of Pennsylvania |
Responsible Party: | Oslin, David - Principal Investigator, Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00018824 |
Other Study ID Numbers: |
MHBS-009-98S |
First Posted: | July 5, 2001 Key Record Dates |
Last Update Posted: | September 23, 2009 |
Last Verified: | September 2009 |
Alcoholism Depression Depressive Disorder Behavioral Symptoms Mood Disorders Mental Disorders Alcohol-Related Disorders Substance-Related Disorders |
Chemically-Induced Disorders Naltrexone Alcohol Deterrents Narcotic Antagonists Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents |